<DOC>
	<DOCNO>NCT00812383</DOCNO>
	<brief_summary>Single center randomize clinical trial , evaluate safety efficacy carotid artery stenting use RX ACCULINK™ Carotid Stent System RX ACCUNET™ Embolic Protection System PercuSurge GuardWire® 3-6 Temporary Occlusion Aspiration System use Angiomax ( bivalirudin ) versus heparin anticoagulant treatment occlusive carotid artery disease low high risk patient cohort .</brief_summary>
	<brief_title>Carotid With Bivalirudin Angioplasty</brief_title>
	<detailed_description />
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<mesh_term>Bivalirudin</mesh_term>
	<mesh_term>Hirudins</mesh_term>
	<criteria>The patient must least 18 year age . The patient must significant diameter reduction extracranial intracranial internal common carotid artery , define ≥50 % stenosis symptomatic patient ≥80 % stenosis asymptomatic patient determine carotid duplex ultrasound scan and/or carotid angiography . Female patient child bear potential must negative pregnancy test . The patient patient 's physician must agree patient return 30day oneyear clinical ultrasound image followup evaluation indicate protocol . Reference vessel diameter ≥ 3.5 mm ≤ 9.0 mm diameter . The patient recent ( &lt; 4 week ) disable stroke dementia major neurologic deficit ( stroke scale : Barthel &lt; 60 , NIH &gt; 15 , Rankin &gt; 3 ) preprocedure neuro exam . The patient within four week treatment procedure intracranial hemorrhage , hemorrhage stroke , major stroke , stroke mass effect demonstrate MRI CT . The patient know allergy heparin , bivalirudin , aspirin antiplatelet agent prevents take aspirin plus ticlopidine aspirin plus clopidogrel . The patient receive fractionate unfractionated heparin within 8 hour prior procedure . The patient history prior lifethreatening radiocontrast reaction pretreated . The patient history bleed diathesis coagulopathy within 3 month . The patient currently participate another study protocol may influence either procedure result followup evaluation . Plasma/serum creatinine &gt; 3.0 mg/dl time intervention . Hemodynamic instability time intervention . Previous stent placement ipsilateral carotid distribution . Angiographic Exclusion Criteria The patient intracranial tumor , cerebral arteriovenous malformation ( ) &gt; 5mm , aneurysm severe intracranial stenosis distal target lesion . The patient inaccessible intracranial arterial stenosis great severity extracranial internal carotid artery lesion . There angiographic evidence significant intraluminal thrombus burden presume increase risk plaque fragmentation consequent distal embolization . There total occlusion ipsilateral carotid artery treatment site TIMI 0 flow characteristic . The reference segment diameter ( internal carotid artery segment cephalad lesion ) less 3 millimeter operator visual estimate . The patient peripheral vascular , supraaortic internal carotid artery tortuosity preclude use catheterbased technique require successful CSSA</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>